GlassScriptPhysician profile
Caroline Benge
NPI 1255708152
$2,106.13
in general payments reported to CMS, 2019-2025
11 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $125 · 2024: $164 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,075 · Travel and Lodging: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.78 |
| Travel and Lodging | $899.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,500.82 | 2023-2025 | Inspire |
| Abiomed | $113.79 | 2025 | |
| Acadia Pharmaceuticals INC | $93.29 | 2024 | Nuplazid |
| Harmony Biosciences LLC | $88.65 | 2022-2024 | |
| Axsome Therapeutics, INC. | $77.15 | 2023-2025 | Sunosi |
| Ultragenyx Pharmaceutical INC. | $63.69 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.42 | 2022 | |
| Jazz Pharmaceuticals INC. | $47.73 | 2023 | |
| Lilly USA, LLC | $31.93 | 2025 | Zepbound |
| Fisher & Paykel Healthcare INC | $28.14 | 2025 | Fisher & Paykel Healthcare |
| 3b Medical, INC. | $10.52 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Benge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.